- Maine Breast Cancer Coalition collaborates with other organizations
to win the battle against breast cancer.
- We advocate for important initiatives for research, treatment, and the end
of breast cancer.
To find out more about current issues in breast cancer advocacy
and legislation visit the
Breast Cancer Coalition web site at www.breastcancerdeadline2020.org
For the latest facts about breast cancer from the
National Breast Cancer Coalition www.knowbreastcancer.org
Take Leadership Role in Ending Breast Cancer
May 3-5, 2015, Maine Breast
Cancer Coalition volunteers Bethany Zell (MBCC President) and Laurel Bezanson
(MBCC Advocacy Committee Chair) once again headed to Washington, DC to
represent MBCC at the 2015 National Breast Cancer Coalition Advocate Leadership
Summit and to meet with Maine's legislators.
Breast Cancer Deadline 2020® is the National
Breast Cancer Coalition's global initiative to know how to end breast cancer by
January 1, 2020. According to Bethany, "As leaders in the breast cancer
movement and supporters of Breast Cancer Deadline 2020®, we are
committed to being a part of this important work."
“In 1989 my life changed. At age 38, I was diagnosed with breast cancer
already had ten positive lymph nodes. My treatment was toxic, expensive and
lengthy. After treatment, I needed to do something to change the status quo.
Subsequently I became involved with the Maine Breast Cancer Coalition and the National Breast Cancer Coalition. I needed to
make a difference in other peoples’ lives that were affected by this
all-too-common disease. I have been an active member of both groups since 1993.
Attending the yearly NBCC Summit is key to ending breast cancer!”
Find out more about how you
can get involved.
The National Breast Cancer Coalition (NBCC) has
a unique history and an unmatched record of accomplishment in breast
cancer. Since NBCC’s inception in 1991, the organization’s mission has
been to end breast cancer. Now, NBCC has set a deadline: Breast
Cancer Deadline 2020® – to know how to end breast cancer by January 1, 2020.
to NBCC, “These are not just words; we have a strategic plan to get
there. While the vast majority of resources are focused on finding the
next treatment, NBCC is doing something very different. We are bringing
together unprecedented collaborations among scientists, visionaries, and
advocates to catalyze, plan and implement work in two major areas: how
to prevent metastasis to save lives and how to prevent the development
of breast cancer.”
Beginning with a baseline report in May 2011,
NBCC has issued Annual Progress Reports about Breast Cancer Deadline
2020®. These reports summarize the state of breast cancer as
well as the status of NBCC’s work to end breast cancer, hold us
and the entire breast cancer community accountable to the Deadline.
Starting in 2013, NBCC convened biennial Leadership Summits to
examine progress and provide guidance and direction for the ongoing work
to achieve Breast Cancer Deadline 2020®.
To find out more about Breast Cancer Deadline
2020 and the National Breast Cancer Coalition go to www.breastcancerdeadline2020.org.
“It’s not just about pink ribbons
. . . people ARE aware of
breast cancer’s path of destruction.”
As Laurel Bezanson of Portland and Bethany Zell of Caribou arrived
Washington, DC on May 3, 3013, they knew that this message would be at the core of
the next four days and were excited to dig in. From new statistics on
breast cancer research to a comprehensive overview of the status quo of breast
cancer incidence and treatment; from discussions on how we can change the
conversation to END breast cancer to the impact of over-diagnosis and over-treatment
of breast cancer; from learning how to mobilize our grassroots efforts at a
local level to the politics that are vital to the end of this disease, the 2013
Inaugural Advocate Leadership Summit of the National Breast Cancer Coalition
did not disappoint.
150 breast cancer advocates from all over the world
came to glean leadership skills and strategies, as well as ideas and advanced
learning on breast cancer. With an intentionally smaller attendance than in
previous years, the advocates from Maine were afforded more intimate
small-group interactions with leaders in the breast cancer community, like Dr.
Susan Love, the president of the Dr. Susan Love Research Foundation and author
of “Dr. Susan Love's Breast Book” and Dr. Dennis Slamon, chief
Hematology and Oncology at UCLA whose research led to the development of the
breast cancer drug, Herceptin.
Tuesday, May 7, as the summit culminated, Laurel and Bethany
had the honor of sharing their experience and knowledge on breast cancer with
each of Maine’s Senators and Congressmen in a whirlwind day on Capitol Hill.
a result of those visits, Senator Susan Collins has again agreed to be a lead
sponsor of the Senate’s Accelerating the
End of Breast Cancer Act, and Rep. Chellie Pingree has signed on to the
House version. Find out more at http://www.breastcancerdeadline2020.org/.
Breast Cancer Coalition representatives, Bethany Zell (left) and Laurel
Bezanson (right), with Senator Susan Collins
Representatives from Maine Breast Cancer
Coalition Attended 2012 Advocate Summit
Release by Bethany Zell, Maine Breast Cancer Coalition volunteer
DC – May 8, 2012
Representing the Maine Breast Cancer Coalition,
Laurel Bezanson of South Portland and Bethany Zell of Caribou attended the National
Breast Cancer Coalition
(NBCC) Advocate Summit in Washington, DC from May 5-8. The summit is
the NBCC’s national meeting of breast cancer advocates from around the
world. There were sessions on the latest scientific research, training
in effective advocacy strategies, and presentations by respected
researchers in the field, grassroots leaders from around the country,
and prominent public policy experts.
The summit also involved advocates
in the work to achieve Breast
Cancer Deadline 2020
- NBCC's strategic plan to end breast cancer by January 1, 2020. The
highlight of the summit was a day on Capitol Hill lobbying for the
“Accelerating the End of Breast Cancer Act” (HR 3067) and the Department
of Defense Breast Cancer Research Program.
Laurel Bezanson and
a fellow attendee from Maine, Bethany Zell of Caribou, met with the
staff of Congressman Mike Michaud and Congresswoman Chellie Pingree, who
had both already signed on to HR 3067. The evening culminated with a
Congressional Reception in the Kennedy Caucus Room of the Russell Senate
At the reception, Maine Senator Susan Collins was awarded
with the NBCC’s Breast Cancer Deadline 2020
Award for her advocacy on behalf of people diagnosed with breast
cancer, and especially for her continuing fight to maintain the
Department of Defense’s Breast Cancer Research Program. While accepting
this award, Senator Collins made the exciting announcement that she
will support the bill for “Accelerating the End of Breast Cancer” once
it is introduced in the Senate.
As a breast cancer survivor and
active member of the Maine Breast Cancer Coalition, Laurel has made it
her mission to inform and advocate for the end of breast cancer and the
National Breast Cancer Coalition’s Breast Cancer Deadline 2020.
the NBCC is gathering signatures on a petition to the President of the
United States. “We want to gather 290,000 signatures in total, one for
each person who will be diagnosed with breast cancer this year.
Regionally, we want to collect 1,485 signatures from the state of Maine
because that is how many people will be diagnosed in Maine this year,”
said Laurel Bezanson.
Shown in photo L to R:
Laurel Bezanson, Senator Collins, Bethany Zell